Company Quick10K Filing
RTI Surgical
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 64 $292
10-K 2019-03-05 Annual: 2018-12-31
10-Q 2018-11-02 Quarter: 2018-09-30
10-Q 2018-08-03 Quarter: 2018-06-30
10-Q 2018-05-04 Quarter: 2018-03-31
10-K 2018-03-02 Annual: 2017-12-31
10-Q 2017-11-03 Quarter: 2017-09-30
10-Q 2017-08-09 Quarter: 2017-06-30
10-Q 2017-05-03 Quarter: 2017-03-31
10-K 2017-03-13 Annual: 2016-12-31
10-Q 2016-11-07 Quarter: 2016-09-30
10-Q 2016-08-04 Quarter: 2016-06-30
10-Q 2016-05-04 Quarter: 2016-03-31
10-K 2016-03-07 Annual: 2015-12-31
10-Q 2015-10-30 Quarter: 2015-09-30
10-Q 2015-07-31 Quarter: 2015-06-30
10-Q 2015-05-04 Quarter: 2015-03-31
10-K 2015-03-04 Annual: 2014-12-31
10-Q 2014-08-01 Quarter: 2014-06-30
10-Q 2014-11-03 Quarter: 2014-06-30
10-Q 2014-05-02 Quarter: 2014-03-31
10-K 2014-03-10 Annual: 2013-12-31
10-Q 2013-11-07 Quarter: 2013-09-30
10-Q 2013-08-07 Quarter: 2013-06-30
10-Q 2013-05-03 Quarter: 2013-03-31
10-K 2013-02-26 Annual: 2012-12-31
10-Q 2012-11-01 Quarter: 2012-09-30
10-Q 2012-08-07 Quarter: 2012-06-30
10-Q 2012-05-02 Quarter: 2012-03-31
10-Q 2011-11-04 Quarter: 2011-09-30
10-Q 2011-08-05 Quarter: 2011-06-30
10-Q 2011-05-02 Quarter: 2011-03-31
10-K 2011-02-22 Annual: 2010-12-31
10-Q 2010-11-08 Quarter: 2010-09-30
10-Q 2010-08-09 Quarter: 2010-06-30
10-Q 2010-05-05 Quarter: 2010-03-31
10-K 2010-03-01 Annual: 2009-12-31
8-K 2019-03-08 Enter Agreement, M&A, Off-BS Arrangement, Shareholder Rights, Control, Officers, Amend Bylaw, Exhibits
8-K 2019-03-08 Regulation FD, Exhibits
8-K 2019-03-07 Shareholder Vote, Regulation FD, Exhibits
8-K 2019-02-28 Earnings, Exhibits
8-K 2019-02-26 Officers
8-K 2019-02-01 Other Events
8-K 2018-11-01 Other Events, Exhibits
8-K 2018-11-01 Earnings, Exhibits
8-K 2018-11-01 Enter Agreement, Exhibits
8-K 2018-09-25 Officers
8-K 2018-08-02 Earnings, Exhibits
8-K 2018-08-01 Shareholder Rights, Amend Bylaw, Exhibits
8-K 2018-06-19 Officers
8-K 2018-06-05 Enter Agreement, Leave Agreement, Off-BS Arrangement
8-K 2018-05-03 Earnings, Exhibits
8-K 2018-04-30 Shareholder Vote
8-K 2018-03-01 Earnings, Exhibits
8-K 2018-02-27 Officers
8-K 2018-01-05 Regulation FD, Exhibits
8-K 2018-01-04 Regulation FD, Exhibits

RTI Surgical Financials

RTIX Metrics, Comps, Filings

Annual | Quarterly

Business

RTI Surgical is a global surgical implant company that designs, develops, manufactures and distributes biologic, metal and synthetic implants. Our implants are used in orthopedic, spine, sports medicine, general surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. We manufacture metal and synthetic implants and process donated human musculoskeletal and other tissue and bovine and porcine animal tissue in producing allograft and xenograft implants using our proprietary BIOCLEANSE®, TUTOPLAST® and CANCELLE® SP sterilization processes. We process tissue at our facilities in Alachua, Florida and Neunkirchen, Germany and manufacture metal and synthetic implants in Marquette, Michigan and Greenville, North Carolina. We are accredited in the U.S. by the American Association of Tissue Banks and we are a member of AdvaMed. Our implants are distributed directly to hospitals throughout the U.S. and in more than 40 countries worldwide with the support of both our and third-party representatives as well as through larger purchasing companies.

We are implementing a transformation strategy to increase focus on our spine and Original Equipment Manufacturer ("OEM") operations and create long-term, profitable growth for the company. In 2017, we introduced a new management team with extensive experience in an effort to spearhead these efforts. The core components of our strategy are:

- Reduce Complexity. We are working to reduce complexity in our organization by divesting non-core assets and investing in core competencies.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Establishment Labs (ESTA) 390,971 59% -14.0 -28% 118,256 74,452 65,316 38,502 -32,594 -24,933 348,412
Park Ohio (PKOH) 387,624 16% 8.3 4% 1,319,000 985,500 1,644,700 265,400 47,300 110,600 919,924
Willis Lease Finance (WLFC) 346,749 62% 7.9 3% 1,930,435 1,535,325 438,122 272,740 61,926 194,966 1,545,242
Sientra (SIEN) 323,974 60% -2.4 -51% 219,882 123,615 79,510 47,802 -111,202 -105,386 248,185
Lawson Products (LAWS) 323,920 53% 16.7 5% 207,738 94,757 282,219 150,540 10,227 18,815 314,494
RTI Surgical (RTIX) 292,200 50% 41.0 -1% 361,186 111,336 280,855 140,123 -3,321 8,050 330,324
Conformis (CFMS) 127,869 48% -4.3 -45% 73,289 53,389 79,589 37,949 -32,915 -27,325 117,871
Northern Technologies International (NTIC) 113,086 32% 16.5 8% 67,511 10,916 55,750 17,780 5,663 6,518 107,229
Invacare (IVC) 260,927 28% 75.7 -4% 847,405 531,926 939,627 262,330 -35,889 5,263 398,168
Lakeland Industries (LAKE) 96,208 34% 15.9 2% 99,104 14,863 79,620 27,271 2,076 5,578 88,423
Shiloh Industries (SHLO) 94,685 9% 7.8 -3% 651,691 484,177 1,054,707 90,576 -19,947 42,453 329,060
Virco Manufacturing (VIRC) 66,783 39% 4.8 5% 139,865 75,316 164,250 64,668 6,692 16,737 80,443
Precision Therapeutics (AIPT) 13,264 72% 105.9 0% 5,416 2,389 1,320 951 0 123 13,054
Alpha Pro Tech (APT) 48,716 37% 11.9 7% 37,864 4,621 35,746 13,130 2,665 3,665 43,610
Hudson Technologies (HDSN) 28,561 10% -18.2 -11% 204,206 149,253 162,027 15,484 -23,276 -6,358 116,006
Rewalk Robotics (RWLK) 23,214 54% -0.8 -42% 28,426 14,311 3,692 2,010 -11,976 -11,972 9,493
Nanovibronix (NAOV) 19,155 69% -3.7 -150% 3,070 840 443 307 -4,601 -4,568 16,897
Milestone Scientific (MLSS) 47,202 69% -10.0 -75% 6,243 7,647 6,074 4,179 -4,661 -4,564 45,491
Myomo (MYO) 13,064 73% -1.1 -131% 6,083 1,664 2,317 1,696 -7,952 -7,952 8,660
Industrial Services of America (IDSA) 9,385 1% -9.3 -13% 24,547 16,631 41,558 276 -3,228 -1,712 15,855

Balance Sheet ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash46,17849,69618,72115,70312,61413,84922,38110,949
Accounts Receivable20,67421,69431,75238,83347,24341,48835,08148,351
Inventory76,59876,509106,126113,464118,673119,743111,927107,471
PP&E44,53249,644128,63977,02884,99283,29879,56477,954
Assets230,027241,409369,854378,135381,065368,031345,906361,186
Accounts Payable11,14111,94923,23126,83420,44626,11218,25226,309
Long-Term Debt591467,70669,41373,63177,26742,07649,073
Liabilities57,60857,417152,264157,466143,386143,099100,246111,336
Stockholders' Equity172,419183,992168,053167,835181,356164,916181,737183,624
Income Statement ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue162,855171,7033,043262,810282,293272,865279,563280,855
Cost of Revenue85,64186,486-77,062129,013132,551140,516137,042140,732
Gross Profit77,21485,21780,105133,797149,742132,349142,521140,123
R&D9,80612,23115,24115,53615,06516,09013,37514,410
SG&A55,57658,37681,635107,653107,439116,125115,103119,217
Tax3,2264,042-11,1105783,667-23819,453-4,331
Net Income8,3788,402-17,8142,69614,915-14,3996,272-1,250
Cash Flow ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating27,76720,803-4,4546,8948,99615,3232,45516,774
Cash Investing-8,484-17,812-142,233-16,314-18,238-17,95238,251-32,737
Cash Financing-1,196517115,6237,8706,2743,664-32,3984,571